| Colon Adenocarcinoma investigated in trials for …INVESTIGATED_IN_TRIALSderived37 of 37show fewer |
|---|
| → investigated in trials for | Fluorouracilsmall_molecule 26 trials (4 active) · roll-up of the cancer and its descendants | — | — | Colon Adenocarcinoma | 26 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Leucovorinsmall molecule 20 trials (3 active) · roll-up of the cancer and its descendants | — | — | Colon Adenocarcinoma | 20 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Oxaliplatinsmall molecule 20 trials (4 active) · roll-up of the cancer and its descendants | — | — | Colon Adenocarcinoma | 20 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Cetuximabmonoclonal antibody 14 trials (5 active) · roll-up of the cancer and its descendants | — | — | Colon Adenocarcinoma | 14 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Irinotecansmall molecule 14 trials (1 active) · roll-up of the cancer and its descendants | — | — | Colon Adenocarcinoma | 14 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Bevacizumabmonoclonal antibody 12 trials (3 active) · roll-up of the cancer and its descendants | — | — | Colon Adenocarcinoma | 12 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Nivolumabmonoclonal antibody 7 trials (4 active) · roll-up of the cancer and its descendants | — | — | Colon Adenocarcinoma | 7 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Regorafenibsmall molecule 5 trials (0 active) · roll-up of the cancer and its descendants | — | — | Colon Adenocarcinoma | 5 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Capecitabinesmall molecule 4 trials (1 active) · roll-up of the cancer and its descendants | — | — | Colon Adenocarcinoma | 4 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Encorafenibsmall molecule 4 trials (3 active) · roll-up of the cancer and its descendants | — | — | Colon Adenocarcinoma | 4 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Erlotinib Hydrochloridesmall molecule 3 trials (0 active) · roll-up of the cancer and its descendants | — | — | Colon Adenocarcinoma | 3 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Afliberceptother 2 trials (0 active) · roll-up of the cancer and its descendants | — | — | Colon Adenocarcinoma | 2 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Atezolizumabmonoclonal antibody 2 trials (2 active) · roll-up of the cancer and its descendants | — | — | Colon Adenocarcinoma | 2 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Ipilimumabmonoclonal antibody 2 trials (0 active) · roll-up of the cancer and its descendants | — | — | Colon Adenocarcinoma | 2 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Panitumumabmonoclonal antibody 2 trials (0 active) · roll-up of the cancer and its descendants | — | — | Colon Adenocarcinoma | 2 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Pembrolizumabmonoclonal antibody 2 trials (1 active) · roll-up of the cancer and its descendants | — | — | Colon Adenocarcinoma | 2 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Pertuzumabmonoclonal antibody 2 trials (0 active) · roll-up of the cancer and its descendants | — | — | Colon Adenocarcinoma | 2 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Trastuzumabmonoclonal antibody 2 trials (0 active) · roll-up of the cancer and its descendants | — | — | Colon Adenocarcinoma | 2 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Tucatinibsmall molecule 2 trials (1 active) · roll-up of the cancer and its descendants | — | — | Colon Adenocarcinoma | 2 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Abemaciclibsmall molecule 1 trials (1 active) · roll-up of the cancer and its descendants | — | — | Colon Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Akt Inhibitor MK2206 1 trials (0 active) · roll-up of the cancer and its descendants | — | — | Colon Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Alisertibsmall molecule 1 trials (0 active) · roll-up of the cancer and its descendants | — | — | Colon Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Binimetinibsmall molecule 1 trials (0 active) · roll-up of the cancer and its descendants | — | — | Colon Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Cabozantinibsmall molecule 1 trials (1 active) · roll-up of the cancer and its descendants | — | — | Colon Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | CAPOX Regimen 1 trials (1 active) · roll-up of the cancer and its descendants | — | — | Colon Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Dasatinibsmall molecule 1 trials (0 active) · roll-up of the cancer and its descendants | — | — | Colon Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Dexamethasonesmall molecule 1 trials (0 active) · roll-up of the cancer and its descendants | — | — | Colon Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | FOLFOX Regimen 1 trials (0 active) · roll-up of the cancer and its descendants | — | — | Colon Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Gefitinibsmall molecule 1 trials (0 active) · roll-up of the cancer and its descendants | — | — | Colon Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Linifanibsmall molecule 1 trials (0 active) · roll-up of the cancer and its descendants | — | — | Colon Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Luminespibsmall molecule 1 trials (0 active) · roll-up of the cancer and its descendants | — | — | Colon Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Nintedanibsmall molecule 1 trials (0 active) · roll-up of the cancer and its descendants | — | — | Colon Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Palbociclibsmall molecule 1 trials (0 active) · roll-up of the cancer and its descendants | — | — | Colon Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Savolitinibsmall molecule 1 trials (0 active) · roll-up of the cancer and its descendants | — | — | Colon Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Sintilimabmonoclonal antibody 1 trials (1 active) · roll-up of the cancer and its descendants | — | — | Colon Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Vorinostatsmall molecule 1 trials (0 active) · roll-up of the cancer and its descendants | — | — | Colon Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Zanidatamabmonoclonal antibody 1 trials (1 active) · roll-up of the cancer and its descendants | — | — | Colon Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |